The effect of elemental Zn boluses on concentrations of Zn in serum and faeces of South American camelids.

Aims: To monitor the effect of using long-acting Zn boluses on the Zn status of a group of South American camelids, using measurements of concentrations of Zn in faeces and serum. Methods: As part of a facial eczema (FE) prevention programme, 15 camelids were treated with long-acting Zn boluses designed for preventing FE in sheep. Based on bodyweight, 13 alpacas (Vicugna pacos) received two boluses (26.4 g Zn/bolus) and two llamas (Lama glama) received three boluses. In order to monitor Zn status, measurements were made of concentrations of Zn in serum and faeces immediately prior to bolus treatment (Week 0) and 4, 6, 8 and 10 weeks later. Gamma glutamyl transferase (GGT) activity in serum was measured at Weeks 0 and 8. Results: Two alpacas regurgitated the boluses; in one case the animal was quickly re-treated but this was not possible in the second animal. Mean concentrations of Zn in faeces were higher at all time points compared to Week 0 (p < 0.001). Peak concentrations were measured at Week 8, and concentrations >120 mg/kg fresh weight (FW), suggested as being protective in calves, were only measured in all (13/13) treated camelids at Week 6. Mean concentrations of Zn in serum differed between weeks of sampling but changes were not consistent, and concentrations did not exceed 18 µmol/L following treatment. There was no evidence of a natural sporidesmin challenge during the study period and activity of GGT in serum of all animals was <45 IU/L. Conclusions: Treatment with Zn boluses significantly increased concentrations of Zn in faeces but not in serum, but peak concentrations in faeces were only detected 8 weeks after treatment. Clinical Relevance: The delay in achieving concentrations of Zn in faeces which were associated with protection against FE in calves, combined with the difficulties of administering boluses to camelids, means that we do not believe that Zn boluses should be used as the primary method for preventing FE in camelids. We recommend that FE prevention in camelids should focus on minimising spore production in pasture through the use of fungicides, grazing management and alternative forages, with boluses only used when it is thought that these methods are unlikely to provide sufficient protection against FE. Such use should always be under the guidance of a veterinarian and monitoring of serum GGT activity should be used to ensure that FE control is being achieved.

A comparison of the effect of short-acting and long-acting cloxacillin-based dry-cow therapy on somatic cell counts after calving in cows also given internal teat sealants.

AIM: To compare, in cows treated with an internal teat sealant, the effect of short-acting and long-acting cloxacillin-based dry-cow therapy on somatic cell counts (SCC) after calving. METHODS: Cows from a spring-calving, pasture-based dairy farm in the Manawatu-Whanganui region of New Zealand were randomly allocated to receive either a short-acting cloxacillin and ampicillin dry-cow therapy and internal teat sealant (n=291) or a long-acting cloxacillin and ampicillin dry-cow therapy and internal teat sealant (n=288) at the end of lactation. Cows were managed on-farm with routine husbandry procedures through the dry period and following calving. A multivariable logistic regression model was used to determine the association between length of action of dry-cow therapy and the proportion of cows with a SCC >150,000 cells/mL at the first herd test after calving. RESULTS: Age of cow, mean SCC for the preceding season and interval from calving to the first post-calving herd test were all associated with the proportion of cows with an individual SCC >150,000 cells/mL at the first herd test (p<0.001) Treatment with the short-acting dry-cow therapy was not associated with decreased odds of cows having a SCC >150,000 cells/mL at the first herd test compared with treatment with long-acting dry-cow therapy (OR=0.724; 95% CI=0.40-1.30). CONCLUSIONS AND CLINICAL RELEVANCE: In this herd, which routinely used internal teat sealants, the use of short-acting cloxacillin-based dry-cow therapy did not result in an increased proportion of cows with elevated SSC post-calving. This was a single farm, single year study but indicates that in this herd, changing from a long-acting to a short-acting antimicrobial may have no impact on the prevalence of subclinical mastitis.